For the Inventor, By the Inventor

Enter assignee name

Ames, IA, United States of America

Newlink Genetics Corporation

USPTO Granted Patents = 21

CIPO Patents = 1

EPO Patents = 8

Trademarks = 1

Forward Citations = 54

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Firoz Jaipuri (19 out of 20 patents)

Mario Mautino (18 out of 19 patents)

Sanjeev Kumar (13 out of 14 patents)

4. Jesse Waldo (13 out of 14 patents)

5. Tanay Kesharwani (8 out of 8 patents)

6. Nicholas N Vahanian (8 out of 8 patents)

7. Charles J Link (7 out of 15 patents)

8. Won-Bin Young (6 out of 6 patents)

9. Gabriela Rossi (5 out of 10 patents)

10. Hima Potturi (4 out of 5 patents)

11. Xiaoxia Zhang (4 out of 4 patents)

12. Richard Pastor (2 out of 23 patents)

13. Xingyu Lin (2 out of 5 patents)

14. Lewis J Gazzard (2 out of 38 patents)

15. Brendan Parr (2 out of 3 patents)

21 patents: Sort by Forward Citations

1. 11827639 - TDO2 and IDO1 inhibitors (2023-11-28),

2. 10800780 - TDO2 Inhibitors (2020-10-13),

3. 10233190 - IDO inhibitors (2019-03-19),

4. 10207990 - Salts and prodrugs of 1-methyl-D-tryptophan (2019-02-19),

5. 10047066 - IDO inhibitors (2018-08-14),

6. 9981973 - Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization (2018-05-29),

7. 9850248 - IDO inhibitors (2017-12-26),

8. 9732035 - Salts and prodrugs of 1-methyl-D-tryptophan (2017-08-15),

9. 9617272 - Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization (2017-04-11),

10. 9512158 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes (2016-12-06),

11. 9388191 - Fused imidazole derivatives useful as IDO inhibitors (2016-07-12),

12. 9260434 - Fused imidazole derivatives useful as IDO inhibitors (2016-02-16),

13. 9174942 - IDO inhibitors (2015-11-03),

14. 9090643 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes (2015-07-28),

15. 8916169 - Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes (2014-12-23),

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products for the treatment of cancer. With a deep expertise in immuno-oncology, the company is dedicated to bringing innovative solutions to patients and healthcare providers. They are committed to advancing their pipeline of product candidates that harness the power of the immune system to fight cancer, aiming to improve patient outcomes and quality of life. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#8 in Ames, IA

#87 in Iowa

#15,183 in US

#29,080 in the World

Ames, IA, United States of America

Newlink Genetics Corporation

Forward Citations = 54

43 inventors:

Firoz Jaipuri (19 out of 20 patents)

Mario Mautino (18 out of 19 patents)

Sanjeev Kumar (13 out of 14 patents)

4. Jesse Waldo (13 out of 14 patents)

5. Tanay Kesharwani (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…